CANCER drug treatments are under scrutiny as a cause of soaring healthcare and claims costs. Current cancer patients will have to brace for changes.
Home Investments Fine-tuning MediShield Life: From 2022, cancer drug treatments must be in “positive...
- Advertisement -
Most Popular
Fed officials split over risks to US economy going into 2026
The Fed cut its benchmark rate by a quarter percentage point for a third consecutive meeting in response to rising unemployment
